| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(88)90030-X |
| P698 | PubMed publication ID | 2898670 |
| P2093 | author name string | A L Beaudet | |
| W E O'Brien | |||
| R Williamson | |||
| G L Feldman | |||
| P2860 | cites work | Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 |
| [21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction | Q29544077 | ||
| Patterns of polymorphism and linkage disequilibrium for cystic fibrosis | Q42131531 | ||
| An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. | Q45889244 | ||
| Experience with new DNA markers for the diagnosis of cystic fibrosis | Q57304813 | ||
| A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands | Q57304822 | ||
| FIRST-TRIMESTER PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS WITH LINKED DNA PROBES | Q57813687 | ||
| Prenatal diagnosis of cystic fibrosis | Q69906611 | ||
| P433 | issue | 8602 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 102 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism | |
| P478 | volume | 2 |
| Q71630939 | A cystic fibrosis patient with delta F508, G542X and a deletion at the D7S8 locus |
| Q40560894 | A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the delta F508 mutation: implications for prenatal diagnosis and mutation origin |
| Q44786062 | A simple assay for the screening of the cystic fibrosis allele in carriers of the Phe508 deletion mutation |
| Q69375480 | Amplification of DNA for detection of cystic fibrosis-linked polymorphisms |
| Q72216757 | Analysis of 160 CF chromosomes: detection of a novel mutation in exon 20 |
| Q24635921 | Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS) |
| Q40420611 | Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping. |
| Q37935121 | Application of the polymerase chain reaction to the diagnosis of human genetic disease |
| Q38343184 | Carrier identification of cystic fibrosis by recombinant DNA techniques |
| Q33683110 | Clinical features of cystic fibrosis patients with rare genotypes |
| Q39564808 | Clinical genetics. A review. |
| Q41637243 | Cystic fibrosis mutations delta F508 and G542X in Jewish patients |
| Q35198298 | Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families |
| Q68904339 | DNA sequence analysis of the KM19 locus linked to cystic fibrosis. Design of new oligonucleotides to remove non-specific PCR products |
| Q41139742 | Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene |
| Q35197304 | Fine-structure genetic mapping of human chromosomes using the polymerase chain reaction on single sperm: experimental design considerations |
| Q71188571 | French CF family genotype analysis shows that the R297Q mutation is a rare polymorphism |
| Q67538623 | Frequency of delta F508 and haplotype association in Austrian cystic fibrosis families |
| Q44509790 | Frequency of delta F508 mutation and haplotype analysis in Austrian cystic fibrosis families |
| Q24675192 | Genetic analysis of DNA from single human oocytes: a model for preimplantation diagnosis of cystic fibrosis |
| Q35888996 | Genetic analysis of Hispanic individuals with cystic fibrosis |
| Q68554079 | Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG) |
| Q42000983 | Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure |
| Q40929203 | Molecular tools for the diagnosis of animal diseases |
| Q56059165 | Polymerase chain reaction |
| Q33597006 | Polymerase chain reaction (PCR) on fixed necropsy material |
| Q69926142 | Prenatal diagnosis of cystic fibrosis where single affected child has died: Guthrie spots and microvillar enzyme testing |
| Q33956378 | Prenatal diagnosis of cystic fibrosis: a case of twin pregnancy diagnosis and a review of 5 years' experience |
| Q33597516 | Reliability of prenatal diagnosis of genetic diseases by analysis of amplified trophoblast DNA. |
| Q30896401 | Risks of fetal cystic fibrosis based on linkage disequilibrium data |
| Q41369290 | Severe liver impairment in a cystic fibrosis-affected child homozygous for the G542X mutation |
| Q33682984 | The Irish cystic fibrosis database |
| Q68184099 | The Kell blood group locus is close to the cystic fibrosis locus on chromosome 7 |
| Q36598571 | The cystic fibrosis defect approached from different angles — new perspectives on the gene, the chloride channel, diagnosis and therapy |
| Q47724112 | The identification of the kappa-casein genotype in Holstein dairy cattle using the polymerase chain reaction |
| Q46870667 | The molecular basis of cystic fibrosis in South Africa |
| Q38206214 | The polymerase chain reaction: an improved method for the analysis of nucleic acids |
| Q33596916 | The polymerase chain reaction: current and future clinical applications |
| Q35889650 | Uniparental isodisomy for paternal 7p and maternal 7q in a child with growth retardation |
| Q40903132 | Universal community carrier screening for cystic fibrosis? |
Search more.